{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:40:55Z","timestamp":1787240455108,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T00:00:00Z","timestamp":1560211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T00:00:00Z","timestamp":1560211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The purpose of this study was to investigate the relationship between clinical disease activity in patients with advanced stage rheumatoid arthritis (RA) on treatment with Disease Modifying Antirheumatic Drugs (DMARDs) and histopathological scores of synovial inflammation. To this end, synovial biopsies of 62 RA patients who underwent surgery for either synovectomy or total joint arthroplasty were assessed by a general synovitis score (GSS) and an immunologic synovitis score (IMSYC). The clinical disease activity index (CDAI) was significantly correlated with both the GSS and the IMSYC (r\u2009=\u20090.65, p\u2009=\u2009&lt;0.001, r\u2009=\u20090.68, p\u2009=\u2009&lt;0.001). Compared to patients with moderate and high disease activity, there was a significantly lower expression of T cell (CD3), B cell (CD20) and neutrophil (CD15) markers in synovial tissue of patients with low activity, but similar expression of the macrophage marker CD68. Subgroup analyses revealed no differences between small and large joints, seropositive and seronegative RA and patients with or without prednisolone treatment. However, we found a significantly stronger correlation of CDAI with IMSYC in patients undergoing arthroplasty (r\u2009=\u20090.82) than in patients undergoing synovectomy (r\u2009=\u20090.55). In addition, there was a stronger correlation of CDAI with GSS in patients treated with methotrexate (r\u2009=\u20090.86) than in patients with TNF\u03b1 blockade (r\u2009=\u20090.55). In summary, the present study demonstrates that the histopathological scores GSS and IMSYC in general reflect clinical disease activity in patients with advanced stage rheumatoid arthritis, but that there is some heterogeneity between subgroups of patients within the cohort. In the future, molecular characterization of synovial inflammatory cell populations, including plasma cell infiltrates, will help to further defined clinically important subtypes of RA and treatment response.<\/jats:p>","DOI":"10.1038\/s41598-019-44895-9","type":"journal-article","created":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T06:02:53Z","timestamp":1560232973000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["General synovitis score and immunologic synovitis score reflect clinical disease activity in patients with advanced stage rheumatoid arthritis"],"prefix":"10.1038","volume":"9","author":[{"given":"Tobias","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Najm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haider","family":"Mussawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Burghardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Oehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veit","family":"Krenn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"R\u00fcther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Niemeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,11]]},"reference":[{"key":"44895_CR1","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1136\/ard.2010.143560","volume":"70","author":"MZ Cader","year":"2011","unstructured":"Cader, M. Z. et al. Performance of the 2010 ACR\/EULAR criteria for rheumatoid arthritis: comparison with 1987 ACR criteria in a very early synovitis cohort. Ann Rheum Dis 70, 949\u2013955 (2011).","journal-title":"Ann Rheum Dis"},{"key":"44895_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/art.10697","volume":"48","author":"ME Weinblatt","year":"2003","unstructured":"Weinblatt, M. E. et al. Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. Arthritis Rheum 48, 35\u201345 (2003).","journal-title":"Arthritis Rheum"},{"key":"44895_CR3","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1136\/annrheumdis-2012-202545","volume":"72","author":"FB Vincent","year":"2013","unstructured":"Vincent, F. B. et al. Antidrug antibodies (ADAb) to tumour necrosis factor (TNF)-specific neutralising agents in chronic inflammatory diseases: a real issue, a clinical perspective. Ann Rheum Dis 72, 165\u2013178 (2013).","journal-title":"Ann Rheum Dis"},{"key":"44895_CR4","doi-asserted-by":"publisher","first-page":"R57","DOI":"10.1186\/ar2678","volume":"11","author":"V Badot","year":"2009","unstructured":"Badot, V. et al. Gene expression profiling in the synovium identifies a predictive signature of absence of response to adalimumab therapy in rheumatoid arthritis. Arthritis Res Ther 11, R57 (2009).","journal-title":"Arthritis Res Ther"},{"key":"44895_CR5","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/j.1365-2559.2006.02508.x","volume":"49","author":"V Krenn","year":"2006","unstructured":"Krenn, V. et al. Synovitis score: discrimination between chronic low-grade and high-grade synovitis. Histopathology 49, 358\u2013364 (2006).","journal-title":"Histopathology"},{"key":"44895_CR6","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/j.1365-2559.2010.03641.x","volume":"57","author":"E Slansky","year":"2010","unstructured":"Slansky, E. et al. Quantitative determination of the diagnostic accuracy of the synovitis score and its components. Histopathology 57, 436\u2013443 (2010).","journal-title":"Histopathology"},{"key":"44895_CR7","first-page":"690","volume":"70","author":"DE Orange","year":"2018","unstructured":"Orange, D. E. et al. Identification of Three Rheumatoid Arthritis Disease Subtypes by Machine Learning Integration of Synovial Histologic Features and RNA Sequencing Data. Arthritis &. Rheumatology 70, 690\u2013701 (2018).","journal-title":"Rheumatology"},{"key":"44895_CR8","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature20810","volume":"542","author":"DA Rao","year":"2017","unstructured":"Rao, D. A. et al. Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis. Nature 542, 110\u2013114 (2017).","journal-title":"Nature"},{"key":"44895_CR9","doi-asserted-by":"crossref","unstructured":"Najm, A. et al. IMSYC IMmunologic SYnovitis sCore: A New Score for Synovial Membrane Characterization In Inflammatory And Non-Inflammatory Arthritis. Joint Bone Spine (2018).","DOI":"10.1136\/annrheumdis-2017-eular.2547"},{"key":"44895_CR10","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha, D. et al. Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62, 2569\u20132581 (2010).","journal-title":"Arthritis Rheum"},{"key":"44895_CR11","first-page":"S-22","volume":"24","author":"H Makinen","year":"2006","unstructured":"Makinen, H., Hannonen, P. & Sokka, T. Definitions of remission for rheumatoid arthritis and review of selected clinical cohorts and randomised clinical trials for the rate of remission. Clin Exp Rheumatol 24, S-22\u201328 (2006).","journal-title":"Clin Exp Rheumatol"},{"key":"44895_CR12","doi-asserted-by":"publisher","first-page":"R796","DOI":"10.1186\/ar1740","volume":"7","author":"D Aletaha","year":"2005","unstructured":"Aletaha, D. et al. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther 7, R796\u2013806 (2005).","journal-title":"Arthritis Res Ther"},{"key":"44895_CR13","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1007\/s00393-015-1571-8","volume":"74","author":"B Kolbel","year":"2015","unstructured":"Kolbel, B. et al. CD15 focus score for diagnostics of periprosthetic joint infections: Neutrophilic granulocytes quantification mode and the development of morphometric software (CD15 quantifier). Z Rheumatol 74, 622\u2013630 (2015).","journal-title":"Z Rheumatol"},{"key":"44895_CR14","first-page":"S100","volume":"23","author":"D Aletaha","year":"2005","unstructured":"Aletaha, D. & Smolen, J. The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol 23, S100\u2013108 (2005).","journal-title":"Clin Exp Rheumatol"},{"key":"44895_CR15","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.3899\/jrheum.081018","volume":"36","author":"P Emery","year":"2009","unstructured":"Emery, P. et al. Less radiographic progression with adalimumab plus methotrexate versus methotrexate monotherapy across the spectrum of clinical response in early rheumatoid arthritis. J Rheumatol 36, 1429\u20131441 (2009).","journal-title":"J Rheumatol"},{"key":"44895_CR16","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/art.20982","volume":"52","author":"JS Smolen","year":"2005","unstructured":"Smolen, J. S. et al. Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study. Arthritis Rheum 52, 1020\u20131030 (2005).","journal-title":"Arthritis Rheum"},{"key":"44895_CR17","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/BF00207484","volume":"72","author":"TC Wascher","year":"1994","unstructured":"Wascher, T. C. et al. Cell-type specific response of peripheral blood lymphocytes to methotrexate in the treatment of rheumatoid arthritis. Clin Investig 72, 535\u2013540 (1994).","journal-title":"Clin Investig"},{"key":"44895_CR18","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nrrheum.2010.5","volume":"6","author":"ESL Chan","year":"2010","unstructured":"Chan, E. S. L. & Cronstein, B. N. Methotrexate\u2014how does it really work? Nature Reviews Rheumatology 6, 175 (2010).","journal-title":"Nature Reviews Rheumatology"},{"key":"44895_CR19","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.4049\/jimmunol.148.7.2201","volume":"148","author":"BN Cronstein","year":"1992","unstructured":"Cronstein, B. N. et al. Neutrophil adherence to endothelium is enhanced via adenosine A1 receptors and inhibited via adenosine A2 receptors. J Immunol 148, 2201\u20132206 (1992).","journal-title":"J Immunol"},{"key":"44895_CR20","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1093\/rheumatology\/34.3.241","volume":"34","author":"AS Williams","year":"1995","unstructured":"Williams, A. S., Punn, Y. L., Amos, N., Cooper, A. M. & Williams, B. D. The effect of liposomally conjugated methotrexate upon mediator release from human peripheral blood monocytes. Br J Rheumatol 34, 241\u2013245 (1995).","journal-title":"Br J Rheumatol"},{"key":"44895_CR21","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1093\/rheumatology\/37.5.502","volume":"37","author":"RJ Dolhain","year":"1998","unstructured":"Dolhain, R. J. et al. Methotrexate reduces inflammatory cell numbers, expression of monokines and of adhesion molecules in synovial tissue of patients with rheumatoid arthritis. Br J Rheumatol 37, 502\u2013508 (1998).","journal-title":"Br J Rheumatol"},{"key":"44895_CR22","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrrheum.2015.169","volume":"12","author":"GD Kalliolias","year":"2015","unstructured":"Kalliolias, G. D. & Ivashkiv, L. B. TNF biology, pathogenic mechanisms and emerging therapeutic strategies. Nature Reviews Rheumatology 12, 49 (2015).","journal-title":"Nature Reviews Rheumatology"},{"key":"44895_CR23","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/art.20764","volume":"52","author":"AI Catrina","year":"2005","unstructured":"Catrina, A. I. et al. Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: extended report. Arthritis Rheum 52, 61\u201372 (2005).","journal-title":"Arthritis Rheum"},{"key":"44895_CR24","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1002\/art.38736","volume":"66","author":"S Glaesener","year":"2014","unstructured":"Glaesener, S. et al. Distinct effects of methotrexate and etanercept on the B cell compartment in patients with juvenile idiopathic arthritis. Arthritis Rheumatol 66, 2590\u20132600 (2014).","journal-title":"Arthritis Rheumatol"},{"key":"44895_CR25","doi-asserted-by":"publisher","first-page":"604","DOI":"10.3899\/jrheum.170366","volume":"45","author":"SM Goodman","year":"2018","unstructured":"Goodman, S. M. et al. Flares in Patients with Rheumatoid Arthritis after Total Hip and Total Knee Arthroplasty: Rates, Characteristics, and Risk Factors. J Rheumatol 45, 604\u2013611 (2018).","journal-title":"J Rheumatol"},{"key":"44895_CR26","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nrrheum.2016.91","volume":"12","author":"IA Udalova","year":"2016","unstructured":"Udalova, I. A., Mantovani, A. & Feldmann, M. Macrophage heterogeneity in the context of rheumatoid arthritis. Nat Rev Rheumatol 12, 472\u2013485 (2016).","journal-title":"Nat Rev Rheumatol"},{"key":"44895_CR27","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/art.40323","volume":"70","author":"ME Weinblatt","year":"2018","unstructured":"Weinblatt, M. E. et al. A Randomized Phase IIb Study of Mavrilimumab and Golimumab in Rheumatoid Arthritis. Arthritis Rheumatol 70, 49\u201359 (2018).","journal-title":"Arthritis Rheumatol"},{"key":"44895_CR28","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/rheumatology\/kex383","volume":"57","author":"X Guo","year":"2018","unstructured":"Guo, X. et al. Blockade of GM-CSF pathway induced sustained suppression of myeloid and T cell activities in rheumatoid arthritis. Rheumatology (Oxford) 57, 175\u2013184 (2018).","journal-title":"Rheumatology (Oxford)"},{"key":"44895_CR29","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nrrheum.2012.23","volume":"8","author":"JS Smolen","year":"2012","unstructured":"Smolen, J. S., Aletaha, D. & Redlich, K. The pathogenesis of rheumatoid arthritis: new insights from old clinical data? Nat Rev Rheumatol 8, 235\u2013243 (2012).","journal-title":"Nat Rev Rheumatol"},{"key":"44895_CR30","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jbspin.2010.08.017","volume":"78","author":"MC Boissier","year":"2011","unstructured":"Boissier, M. C. Cell and cytokine imbalances in rheumatoid synovitis. Joint Bone Spine 78, 230\u2013234 (2011).","journal-title":"Joint Bone Spine"},{"key":"44895_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-02892-y","volume":"9","author":"F Mizoguchi","year":"2018","unstructured":"Mizoguchi, F. et al. Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis. Nat Commun 9, 789 (2018).","journal-title":"Nat Commun"},{"key":"44895_CR32","doi-asserted-by":"crossref","unstructured":"Rivellese, F. et al. Mast cells in early rheumatoid arthritis associate with disease severity and support B cell autoantibody production. Ann Rheum Dis (2018).","DOI":"10.1136\/annrheumdis-2018-213418"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-44895-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-44895-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-44895-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T06:31:49Z","timestamp":1694932309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-44895-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,11]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["44895"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-44895-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,11]]},"assertion":[{"value":"30 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"8448"}}